Back to Search Start Over

miR-133b as a potential regulator of a synaptic NPTX2 protein in Alzheimer's disease.

Authors :
Han SW
Park YH
Bice PJ
Bennett DA
Kim S
Saykin AJ
Nho K
Source :
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Oct; Vol. 11 (10), pp. 2799-2804. Date of Electronic Publication: 2024 Sep 17.
Publication Year :
2024

Abstract

A synaptic protein, Neuronal Pentraxin 2 (NPTX2), has emerged as a pivotal biomarker for Alzheimer's dementia (AD). We identified candidate miRNAs targeting NPTX2 and performed association and mediation analyses using multi-omics data (Nā€‰=ā€‰702). Among 44 candidate miRNAs, miR-133b was significantly associated with AD and Braak positivity. Higher miR-133b expression was also associated with higher NPTX2 gene expression and better cognition. Mediation analysis showed that miR-133b partially influences AD and cognition through the NPTX2 protein. Our integrated approach suggests a potential role of miR-133b in synaptic integrity and offers new insights into AD pathogenesis.<br /> (© 2024 The Author(s). Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.)

Details

Language :
English
ISSN :
2328-9503
Volume :
11
Issue :
10
Database :
MEDLINE
Journal :
Annals of clinical and translational neurology
Publication Type :
Academic Journal
Accession number :
39289904
Full Text :
https://doi.org/10.1002/acn3.52175